Floatz logo

Cyclophosphamide

Childhood Acute Myeloid Leukemia

Fred Hutchinson Cancer CenterSmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

45 Active assets in the Childhood Acute Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
Etoposide
Joanna Yi
Phase 3BBB
Cytarabine
Children's Oncology Group
Phase 3BBB
Nivestim
National Cancer Institute (NCI)
Phase 3BBB
Methotrexate
Children's Oncology Group
Phase 3BBB
Fludarabine
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
mycosis fungoidesActive
BBB
Indicative · Phase 4
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →